Profound Medical Corp (NAS:PROF)
$ 7.15 0.1 (1.42%) Market Cap: 209.63 Mil Enterprise Value: 188.61 Mil PE Ratio: 0 PB Ratio: 5.93 GF Score: 73/100

Profound Medical Corp at Jefferies London Healthcare Conference Transcript

Nov 15, 2022 / 12:20PM GMT
Release Date Price: $5.13 (+4.91%)
Mike Sarcone
Jefferies LLC - (Trades, Portfolio) LLC - Analyst

Okay, we can kick it off. Good afternoon, everyone, and welcome to Jefferies 2022 London Healthcare Conference. My name is Mike Sarcone. I'm an analyst on the US medical supplies and devices team, and we're happy to have with us today Arun Menawat, Chairman and CEO of Profound Medical.

Arun Menawat
Profound Medical Corp. - CEO and Chariman of the Board

Thank you, Mike. It's great to be here at the London Conference, first time for us. So Profound is developing and marketing game-changing technology. So it is quite unique. And I'm going to go through the technology very quickly and talk about where we are in terms of the commercialization.

So the first product that we're marketing is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot